Germany · Human resources startup

medlink

medlink is a Germany-based healthcare staffing technology company that offers a centralized locum tenens staffing system for hospitals.

Funding reportedLast round: Pre-seed

Human resourcesCologne, Germany

About medlink

medlink is a Germany-based healthcare staffing technology company that offers a centralized locum tenens staffing system for hospitals.

Its platform connects hospitals with locum tenens workers and staffing agencies, enhancing the management of substitute shifts and workforce planning. The main service provided by medlink is a digital, web-based staffing and workforce management platform designed for clinics and hospitals. This platform automates substitute-shift administration and connects external medical professionals with healthcare providers, addressing staffing gaps caused by skills shortages. The medlink platform is a mobile- and web-based solution that supports hospital HR and staffing operations. Target users include hospitals, clinics, staffing agencies, and healthcare organizations throughout Germany.

What company datasets say medlink raised

Funding, as reported

Reported in all170kin the source's currency
Rounds2
Last roundPre-seed
Last round size60k
Last round dateFeb 2020
Investors listed2

The company, in detail

What they build

Known for

health careklinikeninformation technology & servicessoftware as a servicehospital & health carepflegepersonalhealthsaasberatungausfallmanagementpersonalvermittlunghealthcarearztepersonalcomputer softwarepersonalbeschaffunghealthcare staffing

Built with from their website

IoTReact NativePWAViewport MetawebpackAIGoogle Font APIMobile FriendlyVercelCreate React App

+7 more

PEOGoogle AnalyticsNode.jsHSTSRemoteGoogle Search ConsoleAndroid

Sector
Human resources
Industry code
NAICS 561320
Region
North Rhine-Westphalia
Full record
Every detail in the company directory

Human resources in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put medlink in front of investors. Or tell us what we have wrong.